BACKGROUND: Despite the high morbidity and mortality of heart failure with preserved ejection fraction (HFpEF), treatment ...
AI-assisted diagnosis of asymptomatic left ventricular dysfunction may detect disease early and thereby expedite treatment of ...
Medera is a clinical-stage biopharmaceutical company focused on targeting difficult-to-treat and currently incurable diseases by developing a range of next-generation therapeutics. Medera operates via ...
In seven patients with Danon disease, a single infusion of adeno-associated virus serotype 9 carrying transgene LAMP2B ...
UK: A secondary analysis of the FINEARTS-HF randomized clinical trial evaluated the performance of the PREDICT-HFpEF model in ...
Does finerenone improve outcomes in patients withheart failure (HF) with mildly reduced or preserved ejection fraction?
The following is a summary of "Stress phase bandwidth as a predictor of left ventricular reverse remodeling in patients with ...
The following is a summary of "Tissue-tracking mitral annular displacement predicts impaired left ventricular mechanics and ...
Medera announced that patient dosing has been completed in its MUSIC-HFrEF Phase 1/2a clinical trial of the gene therapy candidate SRD-001 in ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果